ALLMedicine™ Ovarian Insufficiency Center

May 18th, 2022 - Turner syndrome (TS) is associated with short stature, delayed puberty, primary ovarian insufficiency, and other features. Most girls with TS require oestrogen replacement for pubertal induction. There is paucity of data in adult TS on pubertal ou...

May 15th, 2022 - Surgical menopause (iatrogenic menopause) happens when both ovaries are removed before the natural "switching off" of ovarian function; it can cause premature ovarian insufficiency where the menopause occurs in women before the age of 40. Surgical...

May 13th, 2022 - The specific objective of this protocol is to gain knowledge and collect data in order to allow for hypothesis generation in future research as well as give NICHD investigators and trainees hands on experience related to the diagnoses, management,...

May 10th, 2022 - This is an observational epidemiologic multicentric study of follow-up a cohort for described the situation of patients with primary ovarian insufficiency in public population with respect to the age of apparition the primary ovarian insufficiency...

May 10th, 2022 - To assess sleep disturbances, levels of anxiety, depression and fatigue in women with premature ovarian insufficiency (POI). The study included 62 women with POI and 62 age-matched controls. Women in both groups completed questionnaires. Pittsburg...

Dec 5th, 2017 - Clinical Summary: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women Population Postmenopausal women Postmenopausal women who have had a hysterectomy Recommendation Do not use combined estroge...

Apr 21st, 2017 - Primary ovarian insufficiency describes a spectrum of declining ovarian function and reduced fecundity due to a premature decrease in initial follicle number, an increase in follicle destruction, or poor follicular response to gonadotropins. The s...

Mar 25th, 2016 - What is the optimal management of women with premature ovarian insufficiency (POI) based on the best available evidence in the literature? The guideline development group (GDG) formulated 99 recommendations answering 31 key questions on the diagno...

Jun 15th, 2013 - Molecular genetic testing of the FMR1 gene is commonly performed in clinical laboratories. Mutations in the FMR1 gene are associated with fragile X syndrome, fragile X tremor ataxia syndrome, and premature ovarian insufficiency. This document prov...

May 13th, 2022 - The specific objective of this protocol is to gain knowledge and collect data in order to allow for hypothesis generation in future research as well as give NICHD investigators and trainees hands on experience related to the diagnoses, management,...

May 10th, 2022 - This is an observational epidemiologic multicentric study of follow-up a cohort for described the situation of patients with primary ovarian insufficiency in public population with respect to the age of apparition the primary ovarian insufficiency...

May 5th, 2022 - Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The primary objective remains to preserve the fertility of the respective (minor) patient, facing a very high risk of premature ovarian insuffi...

Apr 5th, 2022 - The investigators propose to study patients with POI who were hospitalized in the endocrinology and reproductive medicine department of the Pitié-Salpêtrière Hospital for the etiological assessment of ovarian failure and its consequences between D...

Apr 4th, 2022 - According to the enrollment and exclusion criteria, the patients were enrolled, and the subjects were randomly divided into two groups by computer randomization. Group A was hormone replacement combined with transplantation of umbilical cord mesen...

Apr 15th, 2022 - In the presentation of secondary amenorrhea, pregnancy is the No. 1 differential diagnosis.

Jan 26th, 2022 - Erin Roesch, MD The residual cancer burden (RCB) quantifies the extent of residual tumor in breast and axillary lymph nodes after neoadjuvant chemotherapy, and has relevance on patient outcomes. In a pooled analysis from 12 institutes in Europe an.

Dec 8th, 2021 - NEW YORK (Reuters Health) - In premenopausal women with early breast cancer, use of a gonadotropin-releasing hormone agonist (GnRHa) during chemotherapy did not increase the risk of cancer recurrence for up to 12 years, including for those with ho...

Oct 6th, 2021 - Reshma Mahtani, DO Findings of a combined analysis of the TEXT and SOFT studies demonstrated a benefit with the addition of ovarian function suppression in premenopausal women with hormone receptor (HR)-positive breast cancer, but the information...

May 18th, 2021 - Primary ovarian insufficiency is not your mother’s early menopause, according to Laurie McKenzie, MD, a reproductive endocrinologist and associate professor of ob. gyn.